Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2011-2-17
pubmed:abstractText
Here we present the first paired-end sequencing of tumors from genetically engineered mouse models of cancer to determine how faithfully these models recapitulate the landscape of somatic rearrangements found in human tumors. These were models of Trp53-mutated breast cancer, Brca1- and Brca2-associated hereditary breast cancer, and E-cadherin (Cdh1) mutated lobular breast cancer.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1465-6914
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
R100
pubmed:meshHeading
pubmed-meshheading:20942901-Animals, pubmed-meshheading:20942901-Animals, Genetically Modified, pubmed-meshheading:20942901-BRCA1 Protein, pubmed-meshheading:20942901-BRCA2 Protein, pubmed-meshheading:20942901-Base Sequence, pubmed-meshheading:20942901-Breast Neoplasms, pubmed-meshheading:20942901-Cadherins, pubmed-meshheading:20942901-Cell Line, Tumor, pubmed-meshheading:20942901-Female, pubmed-meshheading:20942901-Gene Fusion, pubmed-meshheading:20942901-Gene Rearrangement, pubmed-meshheading:20942901-Genomic Library, pubmed-meshheading:20942901-Humans, pubmed-meshheading:20942901-Mice, pubmed-meshheading:20942901-Mutation, pubmed-meshheading:20942901-Receptors, LDL, pubmed-meshheading:20942901-Sequence Deletion, pubmed-meshheading:20942901-Tumor Suppressor Protein p53, pubmed-meshheading:20942901-Tumor Suppressor Proteins
pubmed:year
2010
pubmed:articleTitle
Somatic structural rearrangements in genetically engineered mouse mammary tumors.
pubmed:affiliation
Wellcome Trust Sanger Institute, Hinxton, Cambridge CB101SA, UK. iv3@sanger.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't